Etoxyvon-PG Tablet SR is a combination medication containing Pregabalin 75mg and Etoricoxib 60mg, formulated for sustained release to provide effective and prolonged relief from neuropathic pain and inflammatory conditions. Pregabalin, an anticonvulsant and analgesic agent, works by modulating calcium channels in the nervous system, thereby reducing nerve pain and seizures. Etoricoxib, a selective COX-2 inhibitor, offers potent anti-inflammatory and analgesic effects by blocking the enzyme responsible for inflammation and pain without significantly affecting the stomach lining, making it suitable for patients requiring long-term pain management. Etoxyvon-PG is commonly prescribed for conditions such as diabetic neuropathy, post-herpetic neuralgia, osteoarthritis, rheumatoid arthritis, and chronic musculoskeletal pain. The sustained-release formulation ensures a steady release of active ingredients, enhancing patient compliance by reducing dosing frequency and minimizing side effects. Patients should take Etoxyvon-PG Tablet SR exactly as prescribed by their healthcare provider, and it is important to report any adverse reactions such as dizziness, gastrointestinal discomfort, or allergic responses. Etoxyvon-PG should be used cautiously in patients with renal impairment or cardiovascular risk factors. This combination therapy offers a balanced approach to managing complex pain syndromes by addressing both neuropathic and inflammatory components effectively.